Oxazolidinones, dihydrofuranones, and pyrrolidinones as inactivators and substrates of monoamine oxidase B: Approaches to the design of antiparkinsonian agents

R. B. Silverman*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

5 Scopus citations
Original languageEnglish (US)
Pages (from-to)343-352
Number of pages10
Issue number5
StatePublished - 1997

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Drug Discovery

Cite this